GRCE Competitors & Alternatives
Compare Grace Therapeutics, Inc. with similar stocks in the same industry
Biotechnology
GRCE
Main Stock$2.18
Tradestie Score
54
Market Cap
$42.45M
Analyst Upside
+178.0%
Top Competitors
242 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
OVID
Ovid Therapeutics Inc. Common Stock
|
$2.84
|
$97.42M | - | 45 | Compare |
|
PRLD
Prelude Therapeutics Incorporated
|
$6.74
|
$85.47M | - | 36 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$3.41
|
$84.52M | - | 49 | Compare |
|
CNTB
Connect Biopharma Holdings Limited Ordinary Shares
|
$2.29
|
$83.60M | - | 37 | Compare |
|
UNCY
Unicycive Therapeutics, Inc. Common Stock
|
$5.38
|
$78.68M | - | 39 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$4.56
|
$71.69M | - | 56 | Compare |
|
ARTV
Artiva Biotherapeutics, Inc. Common Stock
|
$11.49
|
$71.32M | - | 47 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$13.57
|
$67.94M | - | 34 | Compare |
|
OSTX
OS Therapies Incorporated
|
$1.52
|
$63.29M | - | 43 | Compare |
|
NEUP
Neuphoria Therapeutics Inc. Common Stock
|
$3.95
|
$26.04M | - | 46 | Compare |
More GRCE Analysis
Data updated: Aug 24, 2026 | Industry: Biotechnology (SIC 2834)
242 stocks in this industry